-+ 0.00%
-+ 0.00%
-+ 0.00%

ARCUS BIOSCIENCES AND SUMMIT THERAPEUTICS ENTER INTO CLINICAL TRIAL COLLABORATION TO EVALUATE CASDATIFAN COMBINED WITH IVONESCIMAB IN KIDNEY CANCER

路透·07/22/2026 20:30:01

登錄查看新聞詳情